AxoGen, Inc. $AXGN is First Light Asset Management LLC's Largest Position

Got story updates? Submit your updates here. ›

First Light Asset Management LLC increased its position in AxoGen, Inc. (NASDAQ:AXGN) by 28.2% in the third quarter, according to the company's 13F filing with the Securities and Exchange Commission. The institutional investor now owns 5,805,730 shares of the medical equipment provider's stock, making it the largest position in its portfolio.

Why it matters

AxoGen is a Florida-based medical technology company that develops and commercializes surgical solutions for peripheral nerve damage. The company's core product portfolio includes the Avance® Nerve Graft and the Axoguard® Nerve Connector and Protector devices. The significant increase in First Light Asset Management's stake in AxoGen suggests the institutional investor sees strong growth potential in the company's products and market position.

The details

First Light Asset Management LLC now owns 12.59% of AxoGen, worth $103,574,000 at the end of the third quarter. The institutional investor added 1,276,487 shares to its position during the period, a 28.2% increase. AxoGen's products are designed to address a range of traumatic and iatrogenic injuries, offering alternatives to traditional nerve autografts.

• First Light Asset Management LLC increased its position in AxoGen in the third quarter of 2026.
• AxoGen's 13F filing with the SEC was released on March 16, 2026.